BIOSPECIFICS TECHNOLOGIES CO's ticker is BSTC and the CUSIP is 090931106. A total of 88 filers reported holding BIOSPECIFICS TECHNOLOGIES CO in Q1 2017. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $80,000 | -19.2% | 1,608 | -11.2% | 0.08% | -8.5% |
| Q1 2017 | $99,000 | -47.3% | 1,810 | -46.4% | 0.08% | +6.5% |
| Q4 2016 | $188,000 | -7.8% | 3,380 | -24.1% | 0.08% | -43.4% |
| Q3 2016 | $204,000 | -1.9% | 4,456 | -14.6% | 0.14% | -12.3% |
| Q2 2016 | $208,000 | -30.9% | 5,215 | -39.7% | 0.16% | -25.8% |
| Q1 2016 | $301,000 | – | 8,642 | – | 0.21% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JW Asset Management, LLC | 73,649 | $3,646,000 | 2.32% |
| Stonepine Capital Management, LLC | 59,878 | $2,965,000 | 1.60% |
| NORTHPOINTE CAPITAL LLC | 109,644 | $5,428,000 | 0.57% |
| Elk Creek Partners, LLC | 145,406 | $7,199,000 | 0.47% |
| TFS CAPITAL LLC | 18,208 | $901,000 | 0.35% |
| RICE HALL JAMES & ASSOCIATES, LLC | 161,671 | $8,004,000 | 0.35% |
| Ativo Capital Management LLC | 19,592 | $970,000 | 0.26% |
| Matarin Capital Management, LLC | 57,034 | $2,823,753,000 | 0.26% |
| ISTHMUS PARTNERS, LLC | 16,505 | $817,000 | 0.24% |
| Stanley-Laman Group, Ltd. | 12,546 | $621,000 | 0.17% |